Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0020672 (
hypothermia
)
17,327
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
A case of familiar bilateral multicentric
RCC
in a young woman is an ideal model to evaluate preoperative and intraoperative diagnostic and surgical tools in order to achieve two distinct goals: the oncologic radicalness and the renal function preserved. Radical bilateral nephrectomy, the renal
hypothermia
by perfusion of both kidneys, the bench high resolution sonography of parenchyma, the choose of one kidney suitable for conservative surgery, the resection of suspect lesions with intraoperative pathology, the reconstructive bench surgery, the autotransplantation, are the steps accurately performed with particular concern to eradication of all the tumoral lesions present in the kidneys. The results confirm that renal function has been preserved with this method. Radicalness should be appointed by a longlasting follow up. However, as it is discussed, conservative surgery, when accurately performed can give results not different from radical demolitive surgery. In this paper tools to improve diagnostic and therapeutic methods are described in order to increase the diagnostic accuracy and the therapeutic efficacy. The possibility that this multiple
RCC
can be a part of the abnormalities occurring in the Von Hippel-Lindau syndrome does not change the surgical approach, being the
RCC
the worst prognostic factor of the syndrome.
...
PMID:[Familial multiple bilateral carcinoma of the kidney: clinical strategy and surgical approach]. 825 84
NS-21, (+/-)-4-diethylamino-1,1-dimethylbut-2-yn-1-yl 2-cyclohexyl-2-hydroxy-2-phenylacetate monohydrochloride monohydrate, is a new drug for the treatment of urinary frequency and incontinence. To evaluate acute toxicities of its related compounds including the optical isomers of NS-21 ((S)NS-21 and (R)NS-21), the active metabolite of NS-21 ((R/S)
RCC
-36), the optical isomers of (R/S)
RCC
-36 ((S)
RCC
-36 and (R)
RCC
-36), the hydrolysis products of NS-21 (
RCC
-32 and
RCC
-38) and the bi-product of NS-21 (
RCC
-66), single-dose intraperitoneal toxicity studies were conducted in ddY mice. The LD50 values of these compounds in male and female mice were as follows: 199 and 184 mg/kg for (S)NS-21, 261 and 240 mg/kg for (R)NS-21, 74 and 100-150 mg/kg for (R/S)
RCC
-36, 93 mg/kg for (S)
RCC
-36 in both sexes, 83 and 104 mg/kg for (R)
RCC
-36, higher than 510 mg/kg for
RCC
-32 in both sexes, 340-510 mg/kg for
RCC
-38 in both sexes, and 1000-2000 mg/kg for
RCC
-66 in both sexes, respectively. The clinical signs included decreased spontaneous locomotor activity, prone or lateral position, ataxic gait, clonic convulsion, hypopnea,
hypothermia
, pale skin, mydriasis, abdominal distention and unkempt fur for (S)NS-21, (R)NS-21, (R/S)
RCC
-36, (S)
RCC
-36 and (R)
RCC
-36, decreased spontaneous locomotor activity, prone position, ataxic gait, clonic convulsion, tail elevation and hypopnea for
RCC
-32 and
RCC
-38, and decreased spontaneous locomotor activity and unkempt fur for
RCC
-66. Body weight was decreased or its gain was suppressed for every compound examined. Pathological examination of the dead mice showed atrophy of the thymus and spleen, intestinal distention with the retention of dark red contents, white spots or white materials in the abdominal fatty tissue for (S)NS-21, (R)NS-21, (R/S)
RCC
-36, (S)
RCC
-36, (R)
RCC
-36 and
RCC
-66, but no treatment related change for
RCC
-32 and
RCC
-38. Adhesion between the abdominal organs was observed in survivors treated with (S)NS-21, (R)NS-21, (S)
RCC
-36, (R)
RCC
-36,
RCC
-32 and
RCC
-66.
...
PMID:[Intraperitoneal single-dose toxicity studies of active metabolite, optical isomers, hydrolysis products and bi-product of (+/-)-4-diethylamino-1,1-dimethylbut-2-yn-1-yl 2-cyclohexyl-2-hydroxy-2-phenylacetate monohydrochloride monohydrate(NS-21), a novel drug for urinary frequency and incontinence, in mice]. 917 Jun 1